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Abstract Monocultures of different placental cells
are used for many physiological and toxicological
studies; however, they are not a true reflection of the
interaction between placenta and fetus. To develop the
most appropriate model to study endocrine and
metabolic properties of fetoplacental unit we used
three co-culture models of placental cells nonfuso-
genic JEG-3, unsyncytialised BeWo (BeWo) and
syncytialised BeWo (syncBeWo) cultured with adre-
nal (H295R) cells. As an end point of endocrine
properties we investigated steroids receptors
expression and steroid secretion, while as metabolic
properties AhR, CYP1A1and COMT expression.
Progesterone (P4), estradiol (E2) and human chorionic
gonadotropin (hCG) secretion (ELISA) and 3bHSD,
CYP19, estrogen (ERa/b), progesterone (PR) and aryl
hydrocarbon (AhR) receptors, CYP1A1 and COMT
protein expression (Western blot) were evaluated.
Comparing three co-culture models we observed: (1)
there were no differences between JEG-3 and BeWo in
the PR expression, however it was higher in BeWo
compared to syncBeWo; (2) there were no differences
in ERa protein expression in all models, while profile
of ERb expression was the highest in syncBeWo; (3)
high P4 secretion in JEG-3 and BeWo while low in
syncBeWo; (4) high E2 levels in JEG-3 and
syncBeWo, while low E2 secretion in BeWo; (5) the
highest hCG secretion in the JEG-3 and syncBeWo
than in BeWo (6) the highest AhR, CYP1A1 and
COMT expression in syncBeWo. Based on the results
showing higher hCG secretion in the JEG-3 than in
BeWo, representing villous and extravillous pheno-
type we suggest that JEG-3 model could be used to
study fetoplacental steroidogenesis at the 1st, while
BeWo model at the 3rd. Results showing comparable
profiles of AhR, CYP1A1 and COMT expression in
JEG-3 and BeWo models and the significantly higher
expression in synBeWo points to synBeWo as a good
model for study the metabolic properties.
Keywords Placenta cell lines  H295R cells 
Fetoplacental steroidogenesis  Fetoplacental
metabolism  Receptors expression
Introduction
Cell-lines derived from human placenta and chorion,
such as human choriocarcinoma cells BeWo or JEG-3
are an alternative for study the placenta function
(Sullivan 2002). There are two main differentiation
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pathways in human placentas, villous (VCT) and
extravillous (EVT) cytotrophoblast (Lee et al. 2016).
BeWo represent placenta villous (Orendi et al. 2010),
while JEG-3 extravillous cells (Lee et al. 2016).
Microarray analysis has indicated that approximately
2700 genes are differentially expressed between
BeWo and JEG-3 cells, suggesting that they are suited
only for specific experimental paradigms. These
differences in gene expression patterns suggest that
JEG3 and BeWo cell lines will vary in their capacity to
respond to an identical experimental treatment
(Burleigh et al. 2007). JEG-3 lines are widely used
to study the molecular mechanisms underlying the
proliferation and invasive potential of cytotrophoblast,
while BeWo cells are commonly used to study
syncytialisation, adhesion and endocrine function
(Hannan et al. 2010). Importantly, BeWo cell lines
have fusogenic properties and, in culture with
forskolin (a cyclic AMP inducer), are able to form
syncytiotrophoblasts (Wice et al. 1990), thus making
them a good third trimester placental model (Zachari-
ades et al. 2011). Moreover, few papers indicate that
significant differences in gene expression promotes
fusion such as: b subunit of human chorionic
gonadotropin, placental alkaline phosphatase,
LGALS13, syncytin-1 or syncytin-2 in BeWo cells
treatment with forskolin compared to non-treated
BeWo cells (Orendi et al. 2010; Frendo et al. 2003).
In the complex scenario of the feto–maternal
interface, endocrine, paracrine, and autocrine factors
must be taken into consideration. Hormones, such as
E2, P4 and hCG are the major players of the endocrine
regulation that take place at the feto–maternal inter-
face. hCG, which is the hormone produced by the
trophoblast in the very early stages of pregnancy, plays
a key role in making sure that the endometrium is
ready to receive the embryo implantation (Tsampalas
et al. 2010). The placenta has poor capacity of
producing de novo estrogen (Escobar et al. 2011),
therefore uses androgens such as dehydroepiandros-
terone (DHEA), derived from the fetal and maternal
adrenal glands to produce estrogen (Gude et al. 2004).
Experimental models using independent cell lines
alone do not reflect the interaction between placenta
and fetus and provide only partial information con-
cerning hormone secretion; moreover, when cultured
alone, cell lines require supplementation with precur-
sors for steroid secretion. The H295R human adreno-
cortical carcinoma cell line possesses all the
enzymatic capacities of the undifferentiated fetal
adrenal gland, and produces androgens, therefore
providing fetal precursors for estrogen (Thibeault
et al. 2014). The expression of PR in BeWo,
syncBeWo and JEG-3 cell lines was described by
Zachariades et al. (2011). Furthermore, two isoforms
of ERs in BeWo cells (Jiang et al. 1997) and JEG-3
cells have also been demonstrated (Mehta et al. 2002).
Additionally, the placenta-expressed enzymes of
phase I (i.e. CYP1A1) and phase II (i.e. catechol-O-
methyl transferase, COMT) of metabolism are respon-
sible for the detoxification of endogenous and exoge-
nous hormones (Isoherranen and Thummel 2013;
Hakkola et al. 1996a). CYP1A1 expression and
activity have been detected in the first and third
trimesters at both mRNA and protein levels (Hakkola
et al. 1996b; Stejskalova and Pavek 2011; Czekaj et al.
2005). There are data showing that both placental
(Hakkola et al. 1996b; Stejskalova et al. 2013) and
adrenal (Bla´ha et al. 2006) CYP1A1 are regulated by
AhR. COMT activity in the full-term placenta has
been described by Barnea et al. (1988). To our
knowledge there are no data showing COMT protein
expression in placenta cell lines.
Coculture models including cells and/or tissues
representative of both the fetus and the maternal
counterpart have been developed to study a wider
spectrum of interactions at the feto–maternal interface
(Wang et al. 2012; Dunk et al. 2003; Helige et al. 2008;
Moser et al. 2010). Such approaches mainly focus on
the invasion of human placenta inside the maternal
decidua. These coculture models are a powerful tool as
they include all the main cell types involved at the
feto–maternal interface. They nevertheless require
synchronization of primary cultures from tissues
which are sometimes difficult to obtain. In order to
overcome these limitations, Mannelli et al. (2015)
recently applied an in vitro system that could be
helpful to study the molecular interactions at the feto–
maternal interface even in laboratories that do not
have availability of fresh tissues. The co-culture of
H295R and BeWo cells as a unique in vitro model to
reproduce the steroidogenic cooperation between fetus
and placenta during pregnancy have been character-
ized and proposed for use to study the endocrine-
disrupting effects of environmental chemicals by
Thibeault et al. (2014). As an end point authors
analyzed progesterone, DHEA, androstenedione,
estradiol, estriol, and estrone, CYP 19 activity and
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hCG production by H295R and BeWo cells in
monoculture or in co-culture over a 24 h period.
In the presented data we decided despite of BeWo
cell line, to use JEG-3 cells with non-fusogenic
properties and syncBeWo representing syncytiotro-
phoblast and additionally as an end point CYP19 and
3b-HSD protein expression, steroid receptors (ERa/b,
PR) protein expression, while for metabolic properties
we selected AhR, CYP1A1 and COMT protein
expression.
Materials and methods
Reagents
DMEM/F12 medium, phosphate buffered saline (PBS),
trypsin were purchased from Gibco Life Technologies
(Paisley, United Kingdom). Fetal bovine serum (FBS,
heat inactivated and stripped) was purchased from
Biowest (Nuaille´, France). NuSerum and ITS ? Pre-
mix were obtained from BD Biosciences (Mississauga,
Ontario, Canada). Insulin, glycerol, ethylenediaminete-
tra-acetic acid (EDTA), dithiothreitol (DTT), bro-
mophenol blue, Na-deoxycholate, Nonidet NP-40,
protease inhibitors (EDTA-free), Tween 20, ammonium
persulfate (APS), N,N,N0N0-tetramethylethylene-di-
amine (TEMED) were obtained from Sigma-Aldrich
(St. Louis,MO, USA). Tris base, NaCl, sodium dodecyl
sulfate (SDS), bovine serum albumin (BSA) were
purchased from Bioshop Canada Inc. (Burlington, ON,
Canada). Methanol and HCl were obtained from
Avantor Performance Materials (Gliwice, Poland).
WesternBrightTMSirius Western blotting detection kit
was obtained from Advansta (Menlo Park, CA, USA).
ABradford protein assay kitwas obtained fromBio-Rad
Laboratories (Hercules, CA, USA). Polyvinylidene
difluoride (PVDF) membrane was purchased from
Merck Millipore (Darmstadt, Germany). Marker of
electrophoresis Thermo Scientific Page Ruler Pre-
stained Protein Ladder was purchased from Thermo
Fisher Scientific (Waltham, MA, USA). Antibodies
were listed in Table 1.
Cell culture
BeWo (cat. CCL-98, ATCC, Manassas, VA, USA)
passages 18–22, JEG-3 (cat. HTB-36, ATTC) pas-
sages 1–6, and H295R (cat. 300483, CLS, Eppelheim,
Germany) passages 17–21 were used in the experi-
ments. All cell lines were cultured in DMEM/F12
without phenol red, supplemented for BeWo cells
with: 0.01 mg/ml insulin and 10% heat-inactivated
FBS, with 10% heat-inactivated FBS for JEG-3 cells
and with 2.5% NuSerum and 1% ITS ? Premix for
H295R cells. BeWo cells have been cultured as non-
differentiated (BeWo) and differentiated (sync.
BeWo) cells. Differentiation was achieved using
50 lM forskolin. Dose of forskolin was selected
based on preliminary experiment with concentrations
of forskolin from 10 to 100 lM and data published by
Zachariades et al. (2011). To select appropriate dose of
forskolin effect on proliferation/cytotoxicity and hor-
mone secretion was examined using Alamar blue
assay and ELISA (data not shown). Firstly BeWo were
cultured in flasks treated with forskolin for 72 h and
then seeded on a plate like syncBeWo. Differentiation
markers like syncytin-1 mRNA expression and hCG
secretion were chosen based on data previously
published by Huang et al. (2009) and analyzed before
and after trypsinization. Moreover, viability was
measured using Alamar Blue test.
Experimental procedure
H295R, BeWo, syncBeWo or JEG-3 (12.5 9 104
cells/200ll/well in 96-well) were cultured alone for
24, 48, and 72 h. At the end of culture, media were
frozen at -20 C for further hormone levels analysis
while cells were lysed with lysis buffer, sonicated and
centrifuged at 15,0009g for 15 min at 4 C and stored
at -20 C for Western blot analysis.
In co-culture BeWo, syncBeWo or JEG-3
cells (1.25 9 104 cells/200ll/well) were cultured on
0.4 lm pores/insert with H295R cells (2.5 9 104
cells/800 ll/well) in 24-well for 72 h. 24 h after
seeding inserts with BeWo or JEG-3 cells were placed
into the wells with H295R cells and media were
replaced with fresh H295R cell medium. Hormone
levels in medium were evaluated after 24, 48, and
72 h. For co-culture, medium was pooled from inserts
and wells. At the end of the incubation period, the cells
from inserts (BeWo or JEG-3) were washed with ice-
cold PBS, lysed with lysis buffer, sonicated and
centrifuged at 15,0009g for 15 min at 4 C and stored
at -20 C for Western blot analysis. Protein expres-
sion was determined in placenta cells (from wells for
monoculture or inserts for co-culture) (Fig. 1)
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Cell density for both types of culture was deter-
mined experimentally in preliminary studies with
3–15 9 104 for placental cells and 20–100 9 104 for
adrenal cells considering size of the plates, time of
culture, cell proliferation and hormone secretion.
Real time PCR
After 24 and 72 h of incubation with PAHs, the cells
were washed with ice-cold PBS, and the plates were
frozen at -20 C until needed for the performance of
PCR analysis. Total RNA isolation and cDNA
synthesis was performed using the TaqMan Gene
Expression Cell-to-CT Kit (Applied Biosystems,
Carlsbad, CA, USA) following the manufacturer’s
protocol. The purity and quantity of the RNA and
cDNA were determined using spectrophotometry at
two optical densities, 260 and 280 nm (DeNovix DS-
11 Spectrophotometer, Wilmington, DE, USA).
Amplifications were performed using the StepOnePlus
system (Applied Biosystems, Carlsbad, CA, USA) and
the TaqMan syncytin-1 in combination with the
TaqMan Gene Expression Master Mix (Applied
Biosystems), following the manufacturer’s instruc-
tions. PCR was performed using a final volume of
20 ll, including 50 ng/reaction cDNA. The PCR
conditions were performed as follows: pre-incubation
for 2 min at 50 C and 10 min at 95 C, amplification
for 40 cycles (15 s at 95 C and 1 min at 60 C). The
relative expression of genes was normalized against
the endogenous reference gene GAPDH (Human
GAPD Endogenous Control, Number 4333764F);
DCq) and converted to relative expression (RQ) using
the 2-DDCq method. The results are expressed in the
figures as relative values (RQ).
Alamar blue assay
The alamarBlue assay (Invitrogen) is designed to
measure the proliferation of different cell types and is
based on quantitation of the cell’s metabolic activity.
Cellular metabolism induces a chemical reduction of
the alamarBlue medium, i.e., this assay is based on the
quantitative metabolic conversion of the blue, nonflu-
orescent resazurin to pink, fluorescent resorufin by
living cells. AlamarBlue has minimal cell toxicity and
is therefore appropriate for continuous monitoring of
proliferation in the same cell culture at various time
points. AlamarBlue stock solution was aseptically
added to the wells in amounts equal to 10% of the
incubation volume. The resazurin reduction in the
cultures after 24 and 72 h of treatment with PAHs was
determined after 3 h incubation with alamarBlue by
measuring the absorbance at 570 nm and 600 nm
wavelengths using a FLUORO microplate reader
(BioTek Instruments, Winooski, VT, USA). The
results are expressed in the figures as relative fluores-
cence units (RFU).
Table 1 Primary and secondary antibodies
Name Cat no. Dillution Company
Primary antibodies
3bHSD goat polyclonal #30820 1:200 Santa Cruz Biotechnology (Danvers, MA, USA)
CYP19 goat polyclonal #14244
CYP1A1 goat polyclonal #9828
COMT rabbit polyclonal #25844
AhR goat polyclonal #8088
ERa rabbit polyclonal #544
ERb rabbit polyclonal #8974
PR A/B rabbit polyclonal #3176S
b-actin rabbit monoclonal #A5316 1:2000 Sigma Aldrich (St. Louis, MO, USA)
Secondary antibodies
Anti-goat horseradish peroxidase-conjugated #sc2020 1:1000 Santa Cruz Biotechnology (Danvers, MA, USA)
Anti-rabbit horseradish peroxidase-conjugated #7074 1:1000 Cell Signaling Technologies (Leiden,
Netherlands)
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ELISA
P4, E2 and hCG levels were determined using
commercially available ELISA kits (cat. EIA-1561,
EIA-2693 and EIA-1911, respectively, DRG Instru-
ments GmbH, Marburg, Germany). For P4 the sensi-
tivity of assay was 0.045 ng/ml. The inter- and intra-
experiment coefficients of variation were 4.34 and
6.99%, respectively. Cross reactivity with P4: 100%,
17aOH progesterone: 0.30%, pregnenolone: 0.35%,
estriol:\0.10% and 17aestradiol:\0.10%. For E2 the
sensitivity of assay was 9.714 pg/ml. The inter- and
intra-experiment coefficients of variation were 6.72
and 2.71%, respectively. Cross reactivity of the E2
assay were tested for E2: 100%, estriol: 0.05%,
estrone: 0.2%, P4: 0% and pregnenolone 0%. For
hCG the sensitivity of assay was 1 mlU/with ranges of
0–200 mlU/ml. The inter- and intra-experiment coef-
ficients of variation were 7.3 and 4%, respectively.
Fig. 1 Experimental procedure
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Western blot
80 lg of protein (determined by the Bradford method)
from each treatment group were separated by 10%
SDS-PAGE and transferred to polyvinylidene difluo-
ride membranes. The blots were blocked for 1 h in 5%
w/v BSA and 0.1% v/v Tween 20 in 0.02 M TBS
buffer and incubated with primary. The blots were
then incubated with primary antibodies listed in
Table 1 diluted 1:200 at 4 C overnight and then with
a horseradish peroxidase-conjugated secondary anti-
body diluted 1:1000. After visualization, blots were
stripped for 30 min using stripping buffer (glycine,
HCl 1% SDS), next blocked 1 h in 5% w/v BSA and
0.1% v/v Tween 20 in 0.02 M TBS buffer and
incubated with primary antibodies for anti-b-actin
diluted 1:2000 at 4 C overnight and then with a
horseradish peroxidase-conjugated secondary anti-
body diluted 1:1000. Signals were detected by
chemiluminescence using a WesternBrightTMSirius,
and visualized using a ChemiDoc-It Imaging System.
Statistical analysis
All samples were analyzed in triplicate in the same
assay and all assays were repeated three times (n = 3).
Experimental results are presented as mean ± S.D.
All statistical analyses were performed using Graph
Pad Prism 5. The data were analyzed by one- or two-
way ANOVA followed by Tukey’s honest significant
differences multiple comparison test. Statistical sig-
nificant differences between time of culture and mono
versus coculture are indicated with different letters
a;b;c;d;e (P\ 0.05), the same letters indicating no
significant differences.
Results
Syncytin-1 gene expression in BeWo
and syncBeWo before and after trypsynization
Before trypsynization, forskolin increased 23 fold
syncytin-1 gene expression (P\ 0.001) (Table 1,
Suppl). After trypsynization syncytin-1 gene
expression was 37 fold higher compared to BeWo
not treated with forskolin (P\ 0.001) (Table 1 in
Supplementary).
Effect of trypsynization on syncBeWo cell’s
viability
24 and 72 h after trypsynization, in both, monoculture
of syncBeWo and co-culture of syncBeWo with
H295R cells no effect on cell proliferation was
observed (Fig. 1 Suppl).
Hormone secretion and steroidogenic enzymes
expression
H295R cells secreted low amount of P4 (Fig. 2A, C,
E) and E2 (Fig. 3A, C, E). In co-cultures of JEG-3 and
BeWo with H295R cells’ P4 secretion was higher than
in the monoculture while in syncBeWo lower versus
monoculture (P\ 0.05) (Fig. 2A, C, E). A similar
pattern was observed for 3bHSD protein expression in
mono- but not in co-culture with JEG-3 cells
(P\ 0.05) (Fig. 2B) and in both mono and co-culture
with BeWo (P\ 0.05) (Fig. 2D). In syncBeWo an
increase in 3bHSD protein expression in monoculture
(P\ 0.05) and no difference in co-culture was noted
(Fig. 2F).
E2 secretion in monoculture of all JEG-3, BeWo
and sync BeWo increased with time of culture. In
JEG-3 with H295R cells co-culture 17, 27 and 21-fold
higher levels of E2 were observed after 24, 48 and
72 h, respectively, and was paralleled with increased
CYP19 protein expression (P\ 0.05) (Fig. 3B). In
the BeWo co-culture model a time dependent effect
was noted compared to monoculture: both E2 secre-
tion and CYP19 expression decreased after 24 h of
culture, increased E2 secretion with decreased CYP19
expression after 48 h of culture and 23-fold higher E2
secretion corresponding with increased CYP19
expression after 72 h of culture was noted (Fig. 3C,
D). In syncBeWo cells co-culture, E2 levels signifi-
cantly increased and was 3.2, 10, and 25-fold higher
after 24, 48 and 72 h, respectively, versus monocul-
ture (P\ 0.05) (Fig. 3E). Significantly increased
CYP19 protein expression in both mono- (after 48 h)
and co-culture (after 72 h) was observed (P\ 0.05)
(Fig. 3F).
Levels of hCG significantly increased with time of
culture in monoculture of all investigated cell lines
(Fig. 4). There was no change in levels with time in
co-culture of JEG-3 with H295R, 3.0, 1.4 and 2.5-fold
higher after 24, 48 and 72 h, respectively, of co-
culture of BeWo with H295R (P\ 0.05) (Fig. 4A, B),
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while in co-culture of sync BeWo with H295R 5.9, 7.1
and 1.2-fold lower levels were observed at 24, 48 and
72 h, respectively (P\ 0.05) (Fig. 4C).
PR protein expression in monoculture was higher in
BeWo than in JEG-3 cells and higher in BeWo than in
syncBeWo cells. The profile of PR protein expression,
in both mono and co-culture of JEG-3 and BeWo cells,
increased during time of cell culture, while no changes
were observed in syncBeWo cells (P\ 0.05)
(Fig. 5A–C). Interestingly, although antibodies
against total PR were used, in fully syncytialised
BeWo cells (treated with 50 lM forskolin for 72 h)
two forms of PR (A ? B) were observed.
The profile of ERa protein expression increased with
time of culture (P\ 0.05) (Fig. 5D–F) in all tested
models; however, expression was significantly higher
in syncBeWo cells in mono- and co-culture with
H295R cells (P\ 0.05) (Fig. 4F). The profile of ERb
in mono- and co-culture of JEG-3 and BeWo cells was
comparable and increased with time of culture, while in
syncBeWo cells there was no change in levels during all
times of culture. (P\ 0.05) (Fig. 5G–I).
The expression of AhR in JEG-3 cells increased
with time of culture both in mono- and co-culture with
H295R cells and reached the highest level after 72 h of
culture (Fig. 6A). In monoculture of BeWo cells, AhR
protein expression decreased after 72 h of culture
while in co-culture expression was lower at 24 h in
comparison with monoculture, and at the same levels
at 48 and 72 h, as in monoculture (P\ 0.05)
(Fig. 6B). In monoculture of syncBeWo cells, AhR
protein expression increased with time of culture and
Fig. 2 P4 secretion and
3bHSD protein expression
in JEG-3 (A, B), BeWo (C,
D) and syncBeWo (E,
F) mono- and co-cultures
with H295R. The protein
levels of 3bHSD (42 kDa)
were densitometrically
scanned and normalised
against the b-actin (42 kDa)
signal. ELISA and Western
blotting experiments were
independently performed
and repeated three times
(n = 3). The data are plotted
as the mean ± S.D.
Statistical significant
differences between time of
culture and mono- versus
co-culture are indicated with
different letters (P\ 0.05),
the same letters indicating
no significant differences
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Fig. 3 E2 secretion and
CYP19 protein expression
in JEG-3 (A, B), BeWo (C,
D) and syncBeWo (E, F)
mono- and co-cultures with
H295R. The protein levels
of CYP19 (50 kDa), were
densitometrically scanned
and normalised against the
b-actin (42 kDa) signal.
ELISA andWestern blotting
experiments were
independently performed
and repeated three times
(n = 3). The data are plotted
as the mean ± S.D.
Statistical significant
differences between time of
culture and mono versus
coculture are indicated with
different letters (P\ 0.05),
the same letters indicating
no significant differences
Fig. 4 hCG secretion in JEG-3 (A), BeWo (B) and syncBeWo
(C) in mono- and co-cultures with H295R. The data are plotted
as the mean ± SD. Statistical significant differences between
time of culture and mono versus coculture are indicated with
different letters (P\ 0.05), the same letters indicating no
significant differences
292 Cytotechnology (2018) 70:285–297
123
was significantly higher than in monoculture of BeWo
cells. In co-culture of syncBeWo cells with H295R
cells, high expression was noted during all times of
culture and this was twofold higher than in co-culture
of BeWo cells with H295R (P\ 0.05) (Fig. 6C).
The profile of CYP1A1 protein expression in
monoculture and co-culture with H295R cells in
JEG-3 cells and BeWo cells was comparable, 2.5 to
threefold higher expression was noted in syncBeWo
cells in mono and co-culture (P\ 0.05) (Fig. 6D–F).
In monoculture of all cell types we noted low protein
expression of COMT. Expression of COMT was
slightly increased at 72 h of co-culture in BeWo cells
with H295R and was the highest in co-culture of
syncBeWo cells with H295R (Fig. 6G–I).
Discussion
In the presented data we compare different steroido-
genic and metabolic parameters in co-cultures of JEG-
3, BeWo and syncBeWo placental cell lines with
an adrenal cell line (H295R).
By comparing co-cultures of placental cells we
showed that both P4 and E2 secretion increased in
JEG-3 and BeWo while in syncBeWo lower P4
secretion was noted. Lower levels of P4 secretion
noted in co-culture of syncBeWo cells could be
explained by the high levels of E2 secreted by the
syncBeWo cells. It is well known that P4 levels during
placentation decrease in favor of increased E2 secre-
tion (Hill 2014) and diminished hCG production
(Aspillaga et al. 1983), which we also observed in our
Fig. 5 Expression of PR A/B and ERa/b in JEG-3 (A, D, G),
BeWo (B, E, H) and syncBeWo (C, F, I) in mono- and co-
cultures with H295R. The protein levels of PR (PR A 118 kDa;
PR B 90 kDa), ERa (65 kDa), and ERb (55 kDa) were
densitometrically scanned and normalised against the b-actin
(42 kDa) signal. Western blotting experiments were
independently performed and repeated three times (n = 3).
The data are plotted as the mean ± S.D. Statistical significant
differences between time of culture and mono- versus coculture
are indicated with different letters (P\ 0.05), the same letters
indicating no significant differences
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study. Although the protein expression profile was
similar in all tested models, the highest expression of
3bHSD was observed in co-culture of syncBeWo
cells. It is well known that 3bHSD enzymes operate
during placental cell differentiation (Meeker et al.
1971).
E2 secretion was significantly higher in all placen-
tal co-culture models compare to monocultures. The
higher levels of E2 secretion can be explained with
increased CYP19 protein expression in all co-culture
models at all time points. Observed by us increased
synergistically E2 secretion in co-culture of H295R
and BeWo after 72 h of culture cells is in accordance
with previously published data (Thibeault et al. 2014).
It is also in agreement with data by Hill (2014),
who showed that progression of development and
differentiation of the placenta is connected with an
increase of placental capacity for the aromatization of
androgens, and therefore with an increase of CYP19
expression or aromatase activity.
Differences in hormone secretion observed in co-
culture models were results from the interaction
between placental and adrenal. For estrogen synthesis,
in contrast to other steroidogenic organ, the placenta
does not express the cytochrome P450 17b-hydroxy-
lase-17:20 lyase, and therefore cannot convert
pregnenolone and progesterone into androgens.
Thus the production of placental estrogens is tributary
of a precursor androgen, the sulphate of
Fig. 6 Protein expression of AhR, CYP1A1 and COMT in
JEG-3 (A, D, G), BeWo (B, E, H) and syncBeWo (C, F, I) in
mono- and co-culture with H295R. The data are plotted as the
mean ± SD. The protein levels of AhR (90 kDa), CYP1A1
(56 kDa), COMT (25 kDa) were densitometrically scanned and
normalised against the b-actin (42 kDa) signal.Western blotting
experiments were independently performed and repeated three
times (n = 3). Statistical significant differences between time of
culture and mono- versus coculture are indicated with different
letters (P\ 0.05), the same letters indicating no significant
differences
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dehydroepiandrosterone (S-DHA) produced by the
maternal and adrenal gland (Thibeault et al. 2014).
We have demonstrated the cell-specific secretion of
hCG in both mono- and co-cultures. The highest level
of secretion of this hormone was noted in the JEG-3
cell; however, there was no difference between
secretion by mono- and co-culture. It has previously
been shown that a large amount of hCG, directly
involved in the quality of placentation, is secreted by
extravillous trophoblasts during the first trimester of
pregnancy and likely hyperglycosylated hCG secre-
tion promotes trophoblast invasion (Handschuh et al.
2007), thus confirming our results. Additionally, we
showed that syncBeWo cells secreted four times more
hCG than BeWo cells which corresponded with lower
P4 levels. As we discussed above, during placentation
P4 levels decrease in favor of an increase in E2
secretion (Hill 2014) and diminished hCG production
(Aspillaga et al. 1983).
No differences between PR expression in JEG-3
and BeWo co-culture, while statistically significant
lower PR expression in co-cultures of syncBeWo cells
were observed. The profile of PR protein expression,
in co-culture of JEG-3 and BeWo, increased over time
of cell culture, while there was no change in
syncBeWo cells. Lower PR expression noted in co-
culture of syncBeWo cell could be explained by lower
P4 secretion corresponding with high levels of E2
secretion and ER expression. Zachariades et al. (2011)
suggested that PR is implicated in the developmental
events leading to placental syncytialisation. Our
observation of the downregulation of PR expression
in syncBeWo cell versus BeWo cells could be justified
by the fact that these cells are fully syncytialised, thus
resembling a third trimester placental model (Zachari-
ades et al. 2011).
From our observation of ER, all used placental cell
lines had higher expression of ERa than ERb. We
noted no significant difference between monoculture
and co-culture of JEG-3 and BeWo cell models
although there was higher ERa expression in sync-
BeWo. This finding is in agreement with the data of
Bukovsky et al. (2003) who showed similar relation-
ships in placental explants. Bukovsky et al. (2003)
documented that E2 plays a role in the stimulation of
terminal differentiation of mononucleated cytotro-
phoblast cells and promotes placental function, via the
ERa. An increase of ERa/bc mRNA in the placenta
throughout gestation was reported by Fujimoto et al.
(2005).
The next important problem discussed in this study
relates to receptor and enzymes involved in the
metabolism of different exogenous and endogenous
compounds. TheAhR acts as a xenobiotic receptor for a
number of different xenobiotics, thus playing a critical
role in human placenta (Stejskalova and Pavek 2011).
We observed statistically significant differences in AhR
expression between the used models with the highest
expression in co-culture of syncBeWo. Taking into
account that there are studies which show multiple
mechanisms of AhR-ER (Helle et al. 2016; Barc´ and
Gregoraszczuk 2016) we suggest that this difference
between the types of model is attributed to higher ER
expression in syncBeWo. The consequence of AhR
receptor stimulation is the activation of detoxifying
enzymes of phase I (CYP1A1) and phase II (i.e.
COMT) of metabolism. In the present study, we
showed comparable CYP1A1 and COMT expression
in JEG-3 and BeWo cells, while higher expression was
observed in syncBeWo cells, both in mono- and co-
culture. CYP1A1 expression and activity have been
detected in the first and third trimesters at both mRNA
and protein levels (Hakkola et al. 1996a, b; Stejskalova
and Pavek 2011; Czekaj et al. 2005). Palmer et al.
(2011) analyzed COMT expression showed that it was
mainly expressed in the syncytiotrophoblast, which
confirms our result of a higher expression of COMT in
syncBeWo. Higher expression of both CYP1A1 and
COMT in syncBeWo cells could be additionally
explained by the fact that both enzymes are important
for the metabolism of estrogens (Parl et al. 2009;
Mannisto and Kaakkola 1999), which were in our co-
culture model produced at the highest amount in
syncBeWo cells compared with JEG-3 and BeWo
cells. The exact molecular mechanism underlying the
difference between unsyncytialised and syncytialised
cells needs further study however it was not a scope of
our study.
Conclusion
Based on our results we conclude that, the difference
in hCG secretion between JEG-3 and BeWo repre-
senting villous and extravillous phenotype could be
used to study fetoplacental steroidogenesis in 1st and
3rd trimester, respectively. In turn syncBeWo model
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exhibiting the highest expression of AhR, CYP1A1
and COMT could be suitable to study the metabolism.
However, taking into consideration that in the devel-
opment and function of the human placenta participate
numerous factors we must keep in mind the limitation
of each experimental model.
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